40 mg/ml
Trade Name
Fomicyt
Powder for solution for infusion
Request Type
New Registration
Drug Type
New Drug
Approval Date
SFDA Approved Use
Fomicyt is indicated in all age groups for the treatment of the following infections when it is considered inappropriate to use antibacterial agents that are commonly recommended for their initial treatment:
- Complicated Urinary Tract Infections
- Infective Endocarditis
- Bone and Joint Infections
- Hospital-Acquired Pneumonia, Including Ventilator-Associated Pneumonia
- Complicated Skin and Soft Tissue Infection
- Bacterial Meningitis
- Complicated Intra-Abdominal Infections
- Bacteremia that occurs in association with, or is suspected to be associated with, any of the infections listed above.
Consideration should be given to official guidance on the appropriate use of antibacterial agents.
- Complicated Urinary Tract Infections
- Infective Endocarditis
- Bone and Joint Infections
- Hospital-Acquired Pneumonia, Including Ventilator-Associated Pneumonia
- Complicated Skin and Soft Tissue Infection
- Bacterial Meningitis
- Complicated Intra-Abdominal Infections
- Bacteremia that occurs in association with, or is suspected to be associated with, any of the infections listed above.
Consideration should be given to official guidance on the appropriate use of antibacterial agents.